FREDERICK, Md., March 3 /PRNewswire-FirstCall/ -- BioElectronics Corporation announced that it has entered into a distribution agreement with Medical Sales Professionals, Inc. (MSP) of Chantilly, Virginia. MSP sells and distributes medical supplies to professional and college sports teams and health care providers, according to Thomas O’Connor, Executive Vice president and COO of BioElectronics.
O’Connor commented, “MSP has been successful in establishing good product usage among professional and college athletics, trainers and physicians. We are very pleased to establish a formal extended relationship with Medical Sales Professionals.”
Ed Suliga, President of MSP, said, “All segments of the healthcare market, particularly sports medicine, are looking for new, less invasive ways to treat soft tissue injuries. Traditional pharmaceutical methods are too costly and risky. ActiPatch(R) Therapy is exceptionally cost effective, easy to use, and efficacious, with no side effects. ActiPatch Therapy is a winning formula in our opinion.” Visit MSP’s web site at http://www.mspinc.net/ .
BioElectronics Corporation is a developer and marketer of advanced, inexpensive, disposable, drug-free, medical devices cleared by the US FDA, the European Union and the Canadian regulatory authorities. ActiPatch(R) Therapy is a dermal patch with an embedded battery operated microchip that delivers weeks of continuous pulsed therapy for a few dollars a day. The patch delivery system and the Company’s patented technology provides an inexpensive, self- administered equivalent of the operator-administered pulsed electromagnetic energy therapy used extensively world-wide to reduce swelling, relieve pain and enhance the healing of post-surgical incisions, chronic wounds (bedsores) and orthopedic conditions. For more information, visit http://www.bioelectronicscorp.com/ .
This news release contains forward-looking statements related to future growth and earnings opportunities. Such statements are based upon certain assumptions and assessments made by management in light of current conditions, expected future developments and other factors it believes to be appropriate. Actual results may differ as a result of factors over which the company has no control.
For further information, contact: Andrew J. Whelan, President & CEO Thomas O’Connor, EVP & COO 301/874-0326 info@bioelectronicscorp.com
BioElectronics Corporation
CONTACT: Andrew J. Whelan, President & CEO, or Thomas O’Connor, EVP &COO, both of BioElectronics Corporation, +1-301-874-0326,info@bioelectronicscorp.com